Thursday, March 3, 2016

Induction of labor in older mothers does not hike the Caesarean section rate! The 35/39 Trial.



Since last 30 years, we have seen a trend of increasing number of women delaying childbirth till later in life, especially in industrialized nation . In a span of 10 years, births to women 35 years and older increased from 12% to 20% in UK.

Women 35 years and  older are at increased risk of antepartum, intrapartum and postnatal complications  like hypertensive disease, gestational diabetes mellitus, placenta previa, and placental abruption and perinatal deaths. They are also at risk of delivering macrosomic or low birth weight infants.

The rate of obstetrical intervention and caesearean deliveries also rises with maternal age, being 38% in nulliparous women over 35 and nearly 50% in those over 40 years of age.

According to Smith GCS et al the gestational week of delivery associated with the lowest cumulative risk of perinatal death was 38 weeks' gestation and the risk of death increased more sharply among primigravid women after 38 weeks' gestation because of a greater risk of antepartum stillbirth.

Currently, in the absence of maternal and fetal complication, routine induction is available to all women in U.K at 41-42 weeks when the risk of still birth is 2-3/1000 live births. However, based on many observational studies, it is a general consensus among obstetrician that induction leads to increased rate of caesarean deliveries and increased perinatal complications.

Trials of induction of labour at term are mostly in women with complications like hypertension, prelabor rupture of membranes, fetal growth restriction, diabetes, or fetal macrosomia. Only few trials involving women with no complications are found in literature, but lack power and are in 1970s. Trials of induction of labour due to advanced maternal age are lacking 

This 35/39 trial was designed to test the hypothesis that induction of labour at 39 weeks in older nulliparous women reduces the risk of operative delivery. The results of the trial was published in March 3, 2016 issue of New England Journal of medicine.

The investigators performed a multicenter, randomized, controlled trial to compare the rate of cesarean section between  women who were induced at 39 weeks and 0 days – 39 weeks and 6 days ( n= 304) with  those who were managed expectantly(n=314). Inclusion criteria were nulliparity, age 35 years or older and carrying a single fetus in cephalic presentation.

The primary outcome was cesarean section and the secondary outcome being other form of vaginal deliveries, onset of labour, augmentation of labour , intrapartum , postpartum and neonatal complications.

The induction of labour was done according to the protocols of the units, but most used prostaglandin ripening followed, if necessary, by amniotomy and oxytocin infusion.

It was seen that there was no significant difference in the rate of cesarean sections between the induction group (98 of 304 women [32%]) vs. (103 of 314 women [33%]) in the expectant group. Also a total of 115 of 304 women (38%) in the induction group delivered vaginally as compared with 104 of 314 women (33%) in the expectant-management group.

The results were also comparable across different maternal age group according to a sub group analysis.

The authors acknowledge the limitations of the trials "the results may not be generalizable to older multiparous women and may not apply to all nulliparous pregnant women who are 35 years of age or older."

The authors further say that “Our trial did not address whether induction of labor at 39 weeks of gestation can prevent stillbirths. It does, however, provide support for the safety of performing a larger trial to test the effects of induction on stillbirth and uncommon adverse neonatal outcomes in women 35 years of age or older, although such a trial would need to be extremely large.”

The journal article was also accompanied by an editorial by William A. Grobman, M.D, from the Northwestern University Feinberg School of Medicine in Chicago, Illinois,  he emphasized that “it would be premature to alter recommendations regarding the timing of delivery in uncomplicated pregnancies. Although the study did not show evidence of harm from induction at 39 weeks of gestation, it also did not show evidence of benefit, and one could argue that medical interventions in general, and intervention in the natural progress of gestation specifically, should be performed only when benefit has been shown.”

He also stressed that the study lacked sufficient power to analyze differences in perinatal outcomes, whether labor induction at 39 weeks of gestation affects these outcomes remains unknown!

He further added “The trial makes an important contribution to medical knowledge. It is the largest trial of its type to be completed, and it suggests that a belief that guides decisions about the timing of delivery — namely, that induction of labor at term increases the risk of cesarean delivery — may not be true after all.”

In summary,the authors concluded “ in women of advanced maternal age, induction of labor at 39 weeks of gestation, as compared with expectant management, had no significant effect on the rate of cesarean section and was not associated with adverse short-term effects on maternal or neonatal outcomes.”

Currently Dr. Groban is the principal investigator for a larger trial to test the effects of induction on stillbirth and uncommon adverse neonatal outcomes. The trial is currently under way within the Maternal–Fetal Medicine Units Network of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. This trial, which has a targeted enrollment of 6000 women, is designed to identify differences in perinatal outcomes among nulliparous women with uncomplicated singleton pregnancies who are randomly assigned to induction between 39 weeks 0 days and 39 weeks 4 days of gestation or to expectant management.


References:

Walker KF, Bugg GJ, Macpherson M, et al. Randomized trial of labor induction in women 35 years of age or older. N Engl J Med 2016;374:813-822

Smith GCS. Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies. Am J Obstet Gynecol 2001;184:489-496

No comments:

Post a Comment